Prof. Andrew Krentz, M.D.

Andrew is an academic physician and researcher with more than three decades of experience at leading institutes in the UK and USA. He contributed with at least 3 papers published by Metadvice. He is the President-Elect of the Vascular, Lipid & Metabolic Section of the Royal Society of Medicine. His clinical focus is the spectrum of cardiometabolic disorders as prominent precursors of vascular disease. Complementing his broad clinical perspective is a range of research expertise that includes pre-clinical and early-phase clinical drug development (as Senior Research Fellow, ProSciento, San Diego, USA), mechanistic clinical trials and epidemiology (the latter gained during a British Heart Foundation International Research Fellowship at the University of California San Diego, USA where he holds a teaching position). He has made several pioneering contributions to translational medicine that have become established therapies. Andrew was the Director of the Institute for Translational Medicine at the University of Buckingham, UK where he was also Professor of Endocrinology & Metabolism and Director of the Clore Life Sciences laboratory. He currently holds the position of visiting Professor of Medical Science at the Institute for Cardiovascular & Metabolic Research, University of Reading, UK. Beyond pharmacotherapeutics he has long recognised that psychological and behavioral factors are barriers to best outcomes in long-term self-managed disorders and that novel approaches are required to span the translational medicine gap between clinical trials and real world practice.

Jérome Voegeli, M.D.

Jérome is an FMH / FAMH certified specialist in hematology and general internal medicine and contributed with one paper published by Metadvice. He is leading the division for hematology of the Volta medico-surgical center in La Chaux-de-Fond and, until 2012 served as a Deputy Head of the Oncology Service in the Canton of Neuchatel responsible for hematology (including hospitals in La Chaux-de-Fonds, Pourtales, Providence and Le Locle). Jérome is an established innovation leader in his field in Switzerland and beyond. He is known for his persistent efforts to accelerate the adoption of recently developed and approved new oncological treatments allowing to dramatically improve the outcomes for his patients. Prior to setting up his private practice in 1998, he worked as chief resident / specialist registrar at the medical polyclinic hospital in Geneva and gained complementary experience at the Centre Hospitalier Universitaire Vaudois (CHUV) for internal medicine and oncology and at the Hôpitaux universitaires de Genève (HUG) for hematology and hemostasis. He is the holder of a Doctorate in Medicine awarded by the University of Lausanne.

Serge Umansky, PhD

Serge is guiding the company strategy in the areas of technology and finance. Serge’s expertise originates from 12 years in science and engineering (focusing on mathematical modelling of complex and nonlinear systems) followed by over 20 years in the investment industry including hands on management of direct investments in private equity and technology ventures with recent specific focus on AI and distributed data systems. Serge started his career as a researcher in numerical analysis and computerized simulations of multi-dimensional non-linear problems related to the aerospace industry and material technologies. He obtained his Doctorate and Ph.D. from the Soviet Academy of Sciences in Kiev. He subsequently worked for over 25 years in the US and Switzerland in senior management roles. His most recent professional engagements include Signet Capital Management (which he co-founded in 2003) and Morgan Creek Capital. While working at Signet, he designed and managed the implementation of an innovative multi-factor risk modelling system for complex investment portfolios. Serge has been an early investor in several venture tech businesses such as Paxos/iTBit and Wirex and served as an advisor in other startup tech projects.

André Jaun, PhD

André is leading the development on the technology front, contributing with more than 6 scientific papers published by Metadvice since the start. His original experience has been in Computational Plasma Physics and Scientific Computing at the Royal Institute of Technology (KTH) in Stockholm where he published 92 scientific papers and supervised several M.Sc. and PhD students while pursuing international collaborations with world leading institutions such as the MIT, the ITER project, and the Universities of Berkeley and Stanford. Andre then changed the focus of his activities to financial markets in 2006 and after 2009 was the head of risk management of the Morgan Creek / Signet group. From 2014 he became a Managing Partner of Renaissance-Data, where he has been developing cross-asset models for proprietary trading applications using artificial intelligence algorithms (deep-learning neural networks) to identify real-time data patterns. He is a holder of an Associate Professor title in Scientific Computing from KTH and a PhD in Plasma Physics from EPF Lausanne.

Jonathan Serjeant, MD

Jonathan is an experienced GP Partner and health care entrepreneur. He is the former CEO of Practice Unbound and Founder/CEO of Here (Care Unbound Ltd) working with over 3000 practices in the UK. He was Co-Founder and Executive Director of Brighton and Hove Integrated care Service (BICS), a social enterprise which develops pathways of care that support people to be in control of their healthcare. Jonathan also led the bid and visioning of EPiC (Extended Primary integrated Care), a successful Prime Ministers Challenge fund bid. BICS underpins the design and implementation of EPiC across 18 GP practices and 20 pharmacies in Brighton. Jonathan is also Founder and Director of the Medical Imaging Partnership, GPnetworks, Optymalhealth Consultancy and an NHS Alliance Executive Team member.

Emily Caldicott

Emily is an experienced senior manager in health-tech development, having set up her own company to develop a new, semi-automated, biometrically- secured e-prescribing platform for the veterinary sector. Her background is as a veterinary surgeon, primarily in critical care, anaesthesia, and mare-and-foal medicine. She became a veterinary clinical director with the largest corporate veterinary group in Australia (Greencross Vets) and she is still a member of the Royal College of Veterinary Surgeons.
Prior to training as a vet, she was a pharmaceutical R&D scientist (Oxford Asymmetry International, Maybridge PLC) and gained a PhD in anti-cancer drug development from the Welsh School of Pharmacy at the University of Cardiff.

Charlotte Kenny, MD

Charlotte began her medical studies at St George's University of London before completing a healthcare business management intercalated degree at King’s College London. Having worked as a Doctor in multiple areas of medicine including Emergency care, General Surgery and Obstetrics she has now focused her efforts in Primary Care. Charlotte is a practising GP in Sussex.
Over the last eight years, she has developed passion around innovation and technology within the health sector, and has demonstrated experience in project change management, including in the implementation of telecommunications within the NHS. Charlotte is an assessor for the NHS innovation accelerator, where she is determined to close the gap between technological possibilities and actual clinical practice.
As Clinical Product Lead at Metadvice, Charlotte connects the multitude of aspects of product development to doctors in real world practice.

Yaron Dibner

Yaron is a graduate from the Ecole Polytechnique Fédérale de Lausanne (EPFL) with an MSc in Computer Science and a specialization in machine learning and image analysis. During his final years he worked in the biological and medical research fields, including a 6-month collaboration with the epidemiology research team of the Geneva University Hospitals (HUG), where he implemented data management solutions for large-scale medical studies. He successfully completed his master thesis at Metadvice on the topic of explainable machine learning (xAI), with the aim of helping doctors to better understand precision medicine recommendations. At Metadvice he co-authored more than 3 scientific publications.